XORTX Therapeutics Inc. (XRTX) stock
XRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.06+0.02 (+1.92%)
Close on Nov 17, 2026Market cap $116.17KP/E –Yield –
XORTX Therapeutics operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
For fiscal 2021 it was -C$6.06M.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | -C$6.06M | – |
| FY2020 | Dec 31, 2020 | -C$728.40K | – |
| FY2019 | Dec 31, 2019 | -C$249.58K | – |
See a number that looks wrong?